M&A News: Roche, Zentiva & Bausch Health 
By

By
The latest news on mergers and acquisitions featuring Roche/89Bio,  Zentiva, Bausch Health/Durect and. Highlights below.  * Roche To Acquire 89Bio To Up MASH Portfolio in $3.5-Bn-Deal* Private Equity Firm To…

Global Briefs: Novartis, Takeda, Biocon & More 
By

By
A roundup of news from Novartis, Takeda, Biocon, Lundbeck and Mabwell Bioscience. Highlights below.   Mfg News * Biocon Opens Expanded US Solid Dosage Mfg Facility Partnering News * Novartis, Monte Rosa in $5.7-Bn…

Novartis to Acquire Tourmaline Bio for $1.4 Bn 
By

By
Novartis has agreed to acquire Tourmaline Bio, a New York-based clinical-stage bio/pharmaceutical company, for $1.4 billion.  Tourmaline’s lead candidate is pacibekitug, an anti-IL-6 monoclonal antibody as a treatment option for…

Lilly Launches AI Drug-Discovery Platform for Biotech Partners 
By

By
Eli Lilly and Company has announced the launch of Lilly TuneLab, an artificial intelligence and machine-learning (AI/ML) platform that provides biotech companies access to drug discovery models trained on Lilly’s…

Pfizer/BioNTech & Moderna Get FDA OK for Updated COVID Vaccines 
By

By
Pfizer/BioNTech and Moderna have each respectively received US Food and Drug Administration (FDA) approval for their supplemental biologics license applications for their LP.8.1-adapted COVID vaccines. The companies reported the approvals…

Supplier News: Enzene, Experic, ProMed & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Enzene, Experic, Made Scientific, Bora Pharmaceuticals, Made Scientific, Nusano, Quotient Sciences, Aenova and GXP Storage.   Chemicals/Chemical API Manufacturing * Nusano Opens Radioisotope Production…

Global Briefs: Merck KGaA, Servier & More 
By

By
A roundup of news from Merck KGaA and Servier/Kaerus Bioscience. Highlights below.   Appointments * Merck KGaA Names New Head of R&D for Healthcare Sector M&A News * Servier To Acquire Autism Drug from…

Roche Breaks Ground on $700-M US Biomanufacturing Facility 
By

By
Roche’s Genentech has broken ground on a new US manufacturing site in Holly Springs, North Carolina, Genentech’s first manufacturing facility on the East Coast. The 65,000-square-meter facility is designed to…

Amgen Investing $600 M in US Science & Innovation Center 
By

By
Amgen has announced plans to invest more than $600 million in a new center for science and innovation at its global headquarters in Thousand Oaks, California. Construction of the facility…

Gilead Breaks Ground on New US Development & Mfg Center 
By

By
Gilead Sciences has broken ground on a new pharmaceutical development and manufacturing technical development center at the company’s Foster City, California, headquarters. The investment is part of Gilead’s planned $32-billion…